Browse diseases

…Objectives Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease. Immune alterations…

… exposure model assigned person-time to non-renal, aPL-negative SLE; LN (biopsy-confirmed or proteinuria is greater than or equal t…

…cally in hyperlipidemic lupus mice following mPSL pulse.Methods SLE was induced using the TLR7 agonist imiquimod (IMQ) in C.KOR/Stm…

…l designed to provide accurate, patient-friendly information on systemic lupus erythematosus (SLE).Methods LupusGPT originated as a direct result of a fishb…

…o identify clinical and socio-demographic correlates of PASS in systemic lupus erythematosus (SLE).Methods We analyzed data from the large multicenter RELES…

…ives Attainment of validated treat-to-target (T2T) endpoints in systemic lupus erythematosus (SLE), such as lupus low disease activity state (LLDAS) and rem…

…s Current clinical serology (e.g., ANA, anti-dsDNA, anti-Sm) in systemic lupus erythematosus (SLE) does not fully capture disease heterogeneity. We recently…

…ne fatigue management programmes (FMPs) in patients living with Systemic Lupus Erythematosus (SLE) in the United Kingdom.Methods Here we present preliminary…

…ymptom, is the most common symptom reported among patients with systemic lupus erythematosus (SLE). This study aimed to characterize the clinical and biolog…

…Objectives Cognitive impairment (CI) is common in people with systemic lupus erythematosus (pwSLE) and negatively impacts quality of life. The underlying …

…Objectives Systemic lupus erythematosus (SLE) is preceded by an at-risk stage of disease that can be ma…

…Objectives Systemic lupus erythematosus (SLE) disease activity leads to irreversible organ damage, if n…